Phased therapeutic intervention improves long-term prognosis of new hemodialysis patients.

Objective: To explore the effect of phased therapeutic intervention in improving the long-term prognosis of new hemodialysis(HD) patients.

Method: This was a retrospective study. A total of 90 new HD patients in Qinhuangdao Haigang Hospital from June 2021 to June 2022 were included and stratified according to their compliance. They were grouped using a random number generator. The control group was given routine nursing intervention, while the intervention group was intervened with phased change nursing intervention. The effects of different intervention modes on patient compliance, biochemical indicators, cardiac function indicators and inflammatory cytokines were compared.

Results: At T, the compliance of the two groups was improved compared with that before the intervention. The compliance of the intervention group at T and T (71.11%, 91.11%) was higher than that of the control group(48.89%, 75.56%), with statistically significant differences( 0.05). At T, the levels of hemoglobin(Hb), hematocrit(Hct), serum iron(SI), transferrin saturation (TS) and left ventricular ejection fraction(LVEF) all increased compared with those before intervention( 0.05), At T and T, Hb, Hct, SI, TS and LVEF in the intervention group were higher than those in the control group( 0.05). At T and T, LVEDD, LVESD and LVWT in the intervention group were smaller than those in the control group( 0.05).

Conclusion: Phased therapeutic intervention can significantly enhance the compliance of new HD patients, as well as further improve their anemia and cardiac function, and reduce inflammatory responses. Therefore, it is worthy of clinical application.